Updates by Region Sponsored by
Kanebo Cosmetics Inc. and its affiliates Lissage Ltd. and E’quipe, Ltd. have recalled brightening products from the Japanese market containing the quasi-drug ingredient rhododenol (4-(4-hydroxyphenyl)-2-butanol (4HPB)). The voluntary recall was initiated after consumers who have used certain brightening products manufactured and sold by Kanebo Cosmetics Inc. and its affiliates Lissage Ltd. and E’quipe Ltd. reported the appearance of white blotches on their skin.
Rhododenol is an active quasi-drug ingredient approved by the Ministry of Health, Labour and Welfare in accordance with the Pharmaceutical Affairs Act after passing extensive safety tests. As long as there is the possibility of a connection between rhododenol and the symptoms mentioned above, Kanebo Cosmetics, Lissage Ltd. and E’quipe Ltd. have decided to voluntarily recall all of their products containing it.
Affected products include:
Following the recall, the U.S. Food and Drug Administration published an advisory on the aforementioned products.